Method of determining a chemotherapeutic regimen based on ERCC1 expression

Details for Australian Patent Application No. 2002249768 (hide)

Owner Response Genetics, Inc.

Inventors Danenberg, Kathleen, D.

Agent Shelston IP

Pub. Number AU-B-2002249768

PCT Pub. Number WO2002/061128

Priority 09/796,491 02.03.01 US; 09/877,095 11.06.01 US; 60/250,121 01.12.00 US; 60/250,470 04.12.00 US; 09/988,784 20.11.01 US

Filing date 29 November 2001

Wipo publication date 12 August 2002

Acceptance publication date 4 January 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 31/7068 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002249768

4 January 2007 Application Accepted

  Published as AU-B-2002249768

3 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002249769-ELEVATOR APPARATUS AND METHOD FOR RUNNING WELL BORE TUBING

2002249767-FLEXIBLE TIP MEDICAL INSTRUMENT